The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007
Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015
Pulmonary arterial hypertension prototype for national protocol and registry Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020 Year: 2020
TOPP: the first international registry in pediatric pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008
Idiopathic pulmonary arterial hypertension in the elderly: Data from the French registry Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011
Incident pulmonary arterial hypertension in a Brazilian reference center: Results of a four-year registry Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013
Childhood pulmonary arterial hypertension: Insights from REVEAL Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017 Year: 2017
Hispanic patients with pulmonary arterial hypertension: Preliminary results from a contemporary national registry Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
A USA-based registry for pulmonary arterial hypertension: 1982 2006 Source: Eur Respir J 2007; 30: 1103-1110 Year: 2007
An international survey of current pulmonary arterial hypertension (PAH) management Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
Impact of functional class change on survival in patients with pulmonary arterial hypertension in the REVEAL registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011
Pulmonary arterial hypertension registries: past, present and into the future Source: Eur Respir Rev, 28 (154) 190128; 10.1183/16000617.0128-2019 Year: 2019
Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018 Year: 2018
Risk assessment in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 390-398 Year: 2016
Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017 Year: 2018
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations Source: Eur Respir Rev, 28 (154) 190050; 10.1183/16000617.0050-2019 Year: 2019
The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019